APOE and amyloidosis: The apoE-MP, although initially intended to treat arthrosclerosis[33–35] is already reported in the literature to improve cognition, decrease amyloid plaque deposition and reduce the number of activated microglia and astrocytes in the APP/PS1ΔE9 mice[31].